CD4+ T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses

Journal of Clinical Investigation

Volumn 102, Issue 3, 1998, Pages 473-482

  Blazar, Bruce R ^a,c   Taylor, Patricia A ^a   Noelle, Randolph J ^b   Vallera, Daniel A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

Allogeneic; Animal models; Immune tolerance; T lymphocytes; Transplantation; Transplantation immunology

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032146529     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3741     Document Type: Article

References (31)

1. Blazar, B.R., R. Korngold, and D.A. Vallera. 1997. Recent advances in graft-versus-host disease prevention. Immunol. Rev. 157:79-109.
2. Grewal, I.S., J. Xu, and R.A. Flavell. 1995. Impairment of antigen-specific T cell priming of mice lacking CD40 ligand. Nature. 378:617-620.
3. Theobald, M., T. Nierle, D. Bunjes, R. Arnold, and H. Heimpel. 1992. Host-specific interleukin-2-secreting donor T cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. N. Engl. J. Med. 327:1613-1617.
4. Jenkins, M.K., and R.H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302-319.
5. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, C. van Kooten, Y.J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
6. Noelle, R.J., M. Roy, D.M. Shepherd, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. A 39-kD protein on activated helper T cells bind CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA. 89:6550-6554.
7. Buhlmann, J.E., T.M. Foy, A. Aruffo, K.M. Crassi, J.A. Ledbetter, W.R. Green, J.C. Xu, L.D. Shultz, D. Roopenian, R.A. Flavell, and R.J. Noelle. 1995. In the absence of a CD40 signal, B cells are tolerogenic. Immunity. 2:645-653.
8. Hollander, G.A., E. Castigli, R. Kulbacki, M. Su, S.J. Burakoff, J.C. Gutierrez-Ramos, and R.S. Geha. 1996. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice. Proc. Natl. Acad. Sci. USA. 93:4994-4998.
9. Durie, F.H., R.A. Fava, T.M. Foy, A. Aruffo, J.A. Ledbetter, and R.J. Noelle. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science. 261:1328-1330.
10. Parker, D.C., D.L. Greiner, N.E. Phillips, M.C. Appel, A.W. Steele, F.H. Durie, R.J. Noelle, J.P. Mordes, and A.A. Rossini. 1995. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. USA. 92:9560-9564.
11. Durie, F.H., A. Aruffo, J. Ledbetter, K.M. Crassi, W.R. Green, L.D. Fast, and R.J. Noelle. 1994. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-versus-host disease. J. Clin. Invest. 94:1333-1338.
12. + T cell mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J. Immunol. 158:29-39.
13. Sha, W.C., C.A. Nelson, R.D. Newberry, D.M. Kranz, J.H. Russell, and D.Y. Loh. 1988. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature. 336:73-76.
14. Kearney, E.R., K.A. Pape, D.Y. Loh, and M.K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity. 1:327-339.
15. Sprent, J., C.D. Surh, D. Agus, D.M. Hurd, S. Sutton, and W.R. Heath. 1994. Profound atrophy of the bone marrow reflecting major histocompatibility complex class II-restricted destruction of stem cells by CD41 cells. J. Exp. Med. 180:307-317.
16. Sprent, J., and J.F. Miller. 1972. Thoracic duct lymphocytes from nude mice: migratory properties and life-span. Eur. J. Immunol. 2:384-387.
17. Schmid, I., C.H. Uittenbogaart, B. Keld, and J.V. Giorgi. 1994. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J. Immunol. Methods. 170:145-157.
18. Lee, R.S., M.J. Grusby, L.H. Glimcher, H.J. Winn, and H. Auchincloss, Jr. 1994. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J. Exp. Med. 179:865-872.
19. Liu, Z., Y.K. Sun, Y.P. Xi, A. Maffei, E. Reed, P. Harris, and N. Suciu-Foca. 1993. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J. Exp. Med. 177:1643-1650.
20. Chen, W., B. Murphy, A.M. Waaga, T.A. Willett, M.E. Russell, S.J. Khoury, and M.H. Sayegh. 1996. Mechanisms of indirect allorecognition in graft rejection: class II MHC allopeptide-specific T cell clones transfer delayed-type hypersensitivity responses in vivo. Transplant. 62:705-710.
21. Vella, J.P., L. Vos, C.B. Carpenter, and M.H. Sayegh. 1997. Role of indirect allorecognition in experimental late acute rejection. Transplant. 64:1823-1828.
22. Liu, Z., A.I. Colovai, S. Tugulea, E.F. Reed, P.E. Fisher, D. Mancini, E.A. Rose, R. Cortesini, R.E. Michler, and N. Suciu-Foca. 1996. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J. Clin. Invest. 98:1150-1157.
23. Sayegh, M.H., and C.B. Carpenter. 1996. Role of indirect allorecognition in allograft rejection. Int. Rev. Immunol. 13:221-229.
24. Fowler, D.H., K. Kurasawa, A. Husebekk, P.A. Cohen, and R.E. Gress. 1994. Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD81 lymphoid engraftment. J. Immunol. 152:1004-1013.
25. + donor T cells fail to induce experimental acute graft-versus-host disease. J. Immunol. 155:585-593.
26. Sprent, J., M. Schaefer, M. Hurd, C.D. Surh, and Y. Ron. 1991. Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype. J. Exp. Med. 174:717-728.
27. Weisdorf, D.J., P.M. Anderson, B.R. Blazar, F.M. Uckun, J.H. Kersey, and N.K.C. Ramsay. 1993. Interleukin-2 immediately after autologous bone marrow transplantation for acute lymphoblastic leukemia: a phase I study. Transplantation. 55:61-66.
28. +, double-positive stage. J. Exp. Med. 184:1619-1630.
29. Falkenberg, J.H.F., W.M. Smit, and R. Wilemnze. 1997. Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia. Immunol. Rev. 157:223-230.
30. Mackall, C., and R. Gress. 1997. Pathways of T cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol. Rev. 157:61-72.
31. Parkman, R., and K.I. Weinberg. 1997. Immunological reconstitution following bone marrow transplantation. Immunol. Rev. 157:73-78.